Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation

Categoria dell'articolo: Research Article

Pubblicato online: 27 ott 2023

Pagine: 15 - 22

Ricevuto: 22 mar 2023

Accettato: 19 lug 2023

DOI: https://doi.org/10.2478/fco-2023-0004

Parole chiave

Chemoradiation, cisplatin, head and neck cancer, neutrophil-to-lymphocyte ratio, prognosis

© 2023 Elisha Servorip Targain et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.